Bupivacaine injection during midurethral sling and postoperative pain: A randomized controlled trial

Gena C. Dunivan, Brent A. Parnell, Anna Marie Connolly, Mary L. Jannelli, Bethany Jablonski Horton, Elizabeth J. Geller

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Introduction: and hypothesis The aim of this study was to investigate the impact of retropubic injection of 0.125% bupivacaine during midurethral sling placement on postoperative pain. Methods: A randomized, double-blind trial of 42 women undergoing midurethral sling for stress incontinence was conducted. The intervention group received an injection of 0.125% bupivacaine in the retropubic space prior to midurethral sling placement, while the control group received no injection. Pain scores were recorded via a 10-cm visual analog scale at 2, 6, and 24 h postoperatively. Results: Pain scores were lower in the bupivacaine group compared to the control group at 2 h (1.9 versus 2.6, p= 0.05). Mean pain scores were similar at all other time points (all p>0.45). Participants in both groups used similar amounts of pain medication in the hospital, except that patients in the bupivacaine group used more PO nonsteroidal anti-inflammatory drugs (p=0.047). Conclusions: Retropubic injection of 0.125% bupivacaine at the time of midurethral sling placement decreases shortterm postoperative pain.

Original languageEnglish (US)
Pages (from-to)433-438
Number of pages6
JournalInternational Urogynecology Journal
Issue number4
StatePublished - Apr 2011


  • Bupivacaine
  • Midurethral sling
  • Postoperative pain

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Urology


Dive into the research topics of 'Bupivacaine injection during midurethral sling and postoperative pain: A randomized controlled trial'. Together they form a unique fingerprint.

Cite this